Our Technology

The Bioprecursor

ALZEX has developed innovative drug candidates called Bioprecursors.

Bioprecursor = Improved prodrug (drug de novo and not a simple delivery system).

Bioprecursor Activated once passed the BBB: biological oxidative pathway
  • Successful design of new drugs for AD modeling commercial FDA approved drugs
  • Bioprecursor technology can be applied to other brain diseases (MULTI DRUG PLATFORM)
Innovative Concept of Bioprecursor
  • Successful design of new drugs for AD modeling commercial FDA approved drugs
  • Bioprecursor technology can be applied to other brain diseases (MULTI DRUG PLATFORM)
Proof of Concept has been achieved
  • Successful design of new drugs for AD modeling commercial FDA approved drugs
  • Bioprecursor technology can be applied to other brain diseases (MULTI DRUG PLATFORM)

Module Technology: How it Works

Using ‘module technology’ drug assembly techniques, we start with an Active Pharmaceutical Ingredient (API) inspired from previous FDA approved drugs. (Old Technology)

01

We draw on the known drug’s action of FDA approved ingredients

02

We then add our proprietary IP for better penetration through the BBBand central vs peripheral selectivity (low level of side-effects)

03

We design a redox switch to trigger the molecule only once it is inside the brain

The Endgame: New API Activated

OLD API

Typical AChe Inhibitor Rivastigmine (Exelon)

Protonated form
- AChe recognition with side effects

Application of the BBB penetration Technology and the redox switch to trigger the molecule only once it is inside the brain.

NEW API Prodrug

Unprotanable nitrogenNo AChE recognition BIOPRESCURSOR

Application of the BBB penetration Technology and the redox switch to trigger the molecule only once it is inside the brain.

Redox switch

Fully charged nitrogenAChE recognition Active Form

Get in Touch with Us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.